Xlife Sciences AG Key word Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23Apr2024 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely responsibl
Xlife Sciences AG / Key word: Annual Results
Xlife Sciences AG Publishes 2023 Annual Report
23-Apr-2024 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The.
Xlife Sciences AG Key word Half Year Results Xlife Sciences with significant progress in H1 2023 21Sep2023 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely re
Xlife Sciences with significant progress in H1 2023 finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
Xlife Sciences AG / Key word(s): PatentXlife Sciences: Swiss portfolio company Axenoll receives strategically significant patent by the European Patent OfficeTitle 20.01.2023 / 07:00 CET/CESTXlife Sciences AG (SIX: XLS) announced today that its Swiss portfolio company Axenoll Life Sciences AG has been granted a stra.